from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2132/-

LFCtreatmentdescriptionclass of inhibitor

0.875

Amikacinug/mL Amikacintranslation

0.774

Cap5-10ug/mL Capreomycintranslation

2.461

Rox10-50 ug/mL Roxithromycintranslation

0.881

SM2-5 ug/mL Streptomycintranslation

1.228

Tet5-10 ug/mL Tetracyclinetranslation

-0.862

Rif0.2-5ug/mL Rifampicintranscription

-0.532

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.847

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.513

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.047

CPZ10-50 ug/mL Chlorpromazinerespiration

0.356

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.105

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.934

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.082

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.232

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.292

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.438

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.201

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.393

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.222

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.885

KCN5-20 ug/mL Potassium cyaniderespiration

-0.959

NaN30.2-2 mM Sodium aziderespiration

1.614

Nigericin50 uM Nigericinrespiration

-0.208

TRC10-150 ug/mL Triclosanrespiration

0.627

TRZ10-25 ug/mL Thioridazinerespiration

3.044

Valinomycin0.5-10 uM Valinomycinrespiration

0.639

ZnSO42 mM ZnSO4respiration

0.648

menadione6-10 ug/mL Menadionerespiration

0.384

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.214

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.100

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.531

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.762

NRP_1Non-replicating persistence stage 1dosRassociated

0.558

Amp0.2mg/mL AmpicillincellWall

-0.059

Cephalexin20-100 ug/mL CephalexincellWall

0.242

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.112

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.055

EMB10-20 ug/mL EthambutolcellWall

0.339

Eta12-40 ug/mL EthionamidecellWall

0.700

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.072

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.018

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.261

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.005

BZA0.12 mg/mL BenzamidearomaticAmides

-0.166

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.024

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.317

H2O24 mM hydrogen peroxideDNAdamaging

-0.294

Levo10 ug/mL LevofloxacinDNAdamaging

0.100

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.834

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.685

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.164

UVUV-irradiationDNAdamaging

-0.519

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.346

Antimycin12.5-50 ug/mL Antimycin A?

0.485

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.805

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.719

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.415

PA8240.2-2 ug/mL PA-824?

-0.320

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.431

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.606

Verapamil50 uM Verapamil?

0.451

mercaptoethanol2 mM 2-Mercaptoethanol?

0.534

methoxatin10-20 ug/mL Methoxatin?